Tag:
Xcellerex
Latest Headlines
Latest Headlines
GE Healthcare grabs Xcellerex to boost biomanufacturing prowess
GE Healthcare ($GE) is snatching up Xcellerex for an undisclosed price, another step in the company's plans to boost its position in biomanufacturing.
GE Healthcare moves further into biopharmaceutical field, buys Xcellerex
GE Healthcare is expanding its line of tools to sell to the biopharmaceutical industry.
CMO Gallus taps Xcellerex for single-use capacity
Fledgling contract manufacturer Gallus Biopharmaceuticals sees something it likes in Xcellerex single-use technology--quick capacity expansion. The two companies agreed this week to a multi-piece
Xcellerex fast-tracks second single-use bioprocessing facility
Xcellerex has started construction on a cGMP biomanufacturing facility based on its portable FlexFactory platform, which incorporates the company's single-use technology. The project, at the
DoD examines 12-week flu vax process
Four Defense Department-funded collaborators have demonstrated swine flu vaccine production within 12 weeks of receiving an unknown target amino acid sequence. The team developed a bioprocess system
My Job: President and CEO, Xcellerex
"My Job" is an occasional item that describes a pharmaceutical manufacturing position from the first-person perspective of someone newly appointed to the job. The intent is to provide over time a
Xcellerex, Humacyte take on regenerative medicine
Disposable bioprocessing technology is taking a step forward in a deal between platform- and service-provider Xcellerex and extracellular matrix tissue-maker Humacyte. Xcellerex will scale up
Pharma turns to small developers for vax tech
Paul Bogorad at Putnam Associates is bullish about the vaccine business. Reviewing the now familiar story line about Big Pharma's embrace of vaccines after years of neglect, Mass High Tech relates
Vax proves out 3-leg business model
Xcellerex's yellow fever vaccine is about to be tested in a Phase I study, marking a clinical-phase milestone for the company. The accomplishment also helps validate the company's disposable
Novavax, Xcellerex double-team H1N1
Novavax is stepping up the pace of its H1N1 vaccine manufacturing process as it works through a two-stage, 4,000-subject trial in Mexico. The novel vaccine maker is working with Xcellerex, using the
